Telomere Therapeutics
PrivateLast Round
Accelerator
Dec 13, 2023
Total Funding Raised
$2.32M
Company Overview
Telomere Therapeutics is a gene therapy company developing disease modifying treatments for unmet medical needs, pioneering the repair of telomeres to treat organ fibrosis and other telomere-dysfunction syndromes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Telomere Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Telomere Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 13, 2023 | ||||
| Grant | Jan 1, 2022 | ||||
| Seed | May 25, 2021 |
Telomere Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arquimedes Accelerator | Accelerator |
| European Commission | Grant |
| Community of Madrid | Grant |
| Center for Technological Development and Innovation | Grant, Seed |
| Invivo Partners | Seed |
| NextGenerationEU | Grant |
| Santander Universities | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 22,253% MoM, from 17 to 3.8K.
- Oct 30, 2024
Monthly visitors grew 529% MoM, from 286 to 1.8K.
Telomere Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Telomere Therapeutics's valuation, stock price, and market status.